ARISTO at a Glance....
CORPORATE IQVIA DATA
Revenues ( RS. IN CRS. )
:
5700.38
Market Share
:
2.90%
Gain in Market Share%
:
-0.12%
Rx Audit Rank (SMSRC) MAT March’25
:
5
Growth
:
3.47%
CAGR (5 years)
:
10.76%
Rank in Indian Pharma Market
:
11
Covered Market Growth%
:
6.73%
Market Share in Covered Market
:
6.15%
Rank in Covered Market
:
3
Front Line Sales Force
:
5100
Source : Stockist Secondary Audit IMS - MAT MAR'25 Dataset
Market Performance
ARISTO has been consistently growing faster than the Indian Pharma Market. This makes us the 3rd largest company in the product segments where we have our presence (IQVIA Feb’25, covered market data).
Corporate Standing
Having grown consistently year over year, we have reached the league of top ten Indian owned pharma organisations by turnover (IQVIA March’25). We have achieved this distinction despite operating with only 7 marketing divisions to promote our product portfolio. On the prescription front, we are ranked 5th (SMSRC prescription audit MAT Apr’24 - Feb’25) which reflects the trust that the medical fraternity has in us.
Brand Power
ARISTO believes in building and nurturing brands to a leadership position in respective segments. The efforts in this direction have made ten brands feature in the coveted top 300 brands of the Indian Pharma Market.
Development & Innovation
Right since its inception, ARISTO has believed in introducing well differentiated formulations backed by its innovative R&D team. As a result, till date, ARISTO has the distinction of introducing over 21 formulations for the first time in India.
